SUN11602;4-[[4-[[2-[(4-Amino-2,3,5,6-tetramethylphenyl)amino]acetyl]methylamino]-1-piperidinyl]methyl]benzamide;CS-2504;SUN11602;SUN11602;inhibit,Fibroblast growth factor receptor,SUN11602,FGFR,Inhibitor,SUN-11602;Benzamide, 4-[[4-[[2-[(4-amino-2,3,5,6-tetramethylphenyl)amino]acetyl]methylamino]-1-piperidinyl]methyl]-;SUN11602, 10 mM in DMSO;4-[[4-[[2-(4-amino-2,3,5,6-tetramethylanilino)acetyl]-methylamino]piperidin-1-yl]methyl]benzamide
SUN11602 is a novel basic aniline compound with fibroblast growth factor activity; it prevents glutamate-induced neuronal death in primary cultures of rat cerebrocortical neurons; increases CALB1 gene expression levels in cerebrocortical neurons; exerts protective effects on hippocampal neurons through activation of FGFR1 and upregulation of Calbindin (CalB) expression; promotes neurite outgrowth in primarily cultured rat hippocampal neurons; enhances newly synthesized Calb levels in cerebrocortical neurons of wild-type mice and suppresses glutamate-induced intracellular Ca²⁺ elevation; attenuates short-term memory impairment in the Y-maze test and spatial learning deficits in the water maze task when administered orally during Aβ1-40 and ibotenate injections; inhibits the increase of peripheral-type benzodiazepine-binding sites (PTBBS), a marker for gliosis.